✦ LIBER ✦

Cost Effectiveness of Tenofovir Disoproxil Fumarate for the Treatment of Chronic Hepatitis B from a Canadian Public Payer Perspective

✍ Scribed by Dakin, Helen; Sherman, Morris; Fung, Scott; Fidler, Carrie; Bentley, Anthony

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tenofovir disoproxil fumarate for the tr

✍ Wai-Kay Seto, Man-Fung Yuen, James Fung, Ching-Lung Lai 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 206 KB

Tenofovir disoproxil fumarate in the tre

✍ Jenh, Alice M ;Pham, Paul A 📂 Article 📅 2010 🏛 Expert Reviews 🌐 English ⚖ 958 KB

Cost–Utility Analysis of Tenofovir Disop

✍ Helen Dakin; Anthony Bentley; Geoff Dusheiko 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 317 KB

Cost Effectiveness Analysis Of Tenofovir

✍ Soto, H.; Botello, B.S.; Pizarro, M.; Rizzoli, A.; Gozález, L.A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Regression of cirrhosis during treatment

✍ Marcellin, Patrick; Gane, Edward; Buti, Maria; Afdhal, Nezam; Sievert, William; 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 242 KB

Cost-effectiveness analysis of treatment

✍ Barros, Fabio MR; Cheinquer, Hugo; Tsuchiya, Carolina T; Santos, Eduardo AV 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 363 KB